The global thoracic drainage devices market is anticipated to reach a market size of around US$ 900 Mn by 2027 and is anticipated to grow at a CAGR of around 4% in terms of revenue during the forecast period 2020 – 2027
Thoracic tube thoracostomy or insertion of the chest tube is a very painful operation to remove air, fluid, or blood from the thoracic cavity to prevent collapse of the lungs. A thoracic catheter, chest drain or intercostal drain is also referred to as a chest tube. In the pleural room is inserted the thoracic catheter. It requires the use of multiple techniques including trocar drainage, thoracic drainage device, unsecured nail, sealed needle, catheter for pleural drainage and thoracic drainage pack. Thoracic drainage equipment is used mainly for signs of pleural effusion, traumatic pneumothorax, and heart surgery operation (pneumothorax, gunshot or stab wound).
Rising cardiovascular occurrence and prevalence and the growing risk of spontaneous pneumothorax are main factors which are projected to fuel market growth in the next 10 years. The increasing prevalence of cardiovascular conditions such as diabetes, hypertension and obesity are mainly leading to a growing amount of open medical operations around the world.
Moreover, increased demand for reduced invasive surgeries, higher healthcare costs, developments in surgical device technology are factors that fuel the demand worldwide for chest drainage device. However, less accessibility and lack of access for trained healthcare professionals are some of the reasons that are projected to limit the growth of the target market in a certain measure. In particular in developing and developing region.
Hospitals and Specialty Care Remain Central to Patients Surgical Needs
Despite a rise in thoracic drainage applications, including heart surgery, military damage assessment and general intensive care, thoracic procedure and pulsation applications are winning the market with a forecast ~40 percent share in the 2019 thoracic drainage system. The growth in thoracic operations is expected to lead to demand for thoracic drilling equipment because of the increasing hospital stay of pneumothorax and pleural effusions. However, in the light of the ease provided by innovative and early diagnostic technology for the diagnosis of tumours, there has been a sharp growth in oncology and pain relief applications.
The US dominated the global thoracic drainage devices market. This domination is primarily attributed to variables like high product prices and a high degree of user sensitivity. Moreover, the US market is driven by the growing use of newly-established cardiovascular surgical instruments and insurance policies. The global thoracic drainage device market is the second-largest provider in Europe. Germany contributes significantly to the European market of thoracic drainage products. The Asia-Pacific market of thoracic drainage equipment is increasing quick, led by developing countries. The demand for chest drainage devices in Asia Pacific is driven by growing understanding of cardiovascular disorders and healthcare expenses.
The players profiled in the report include MAQUET Holding B.V. & Co. KG., Vygon, Cook, Teleflex Incorporated, C. R. Bard, Inc., Smiths Medical, Utah Medical Products, Inc., Sinapi Biomedical, ATMOS MedizinTechnik GmbH & Co. KG, Medela AG, and others are the prominent players in the market.
The global thoracic drainage devices market is segmented as below:
Thoracic Drainage Devices Market By Product Type
Thoracic Drainage System
Pleural Drainage Catheter
Thoracic Drainage Kit
Thoracic Drainage Devices Market By Application
Thoracic Surgery and Pulmonology
General Intensive Care and Emergency Medicine
Oncology and Pain Management
Military/Damage Control/Disaster Medicine
Thoracic Drainage Devices Market By End User
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
Others (include, Ambulance Services, Outpatient Care, etc.)
Thoracic Drainage Devices Market By Geography
Middle East & Africa
The market for thoracic drainage devices is expected to reach a market value of around US$ 900 Mn by 2027.
The thoracic drainage devices market is expected to grow at a CAGR of around 4% from 2020 to 2027
The thoracic surgery and pulmonology is the leading segment by application in the thoracic drainage devices market
Horacic drainage devices are utilized in the treatment of pneumothorax pleural effusions, and empyema disorders is the major drivers which propelled the demand of the thoracic drainage devices market in the forecast period.
MAQUET Holding B.V. & Co. KG., Vygon, Cook, Teleflex Incorporated, C. R. Bard, Inc., Smiths Medical, Utah Medical Products, Inc., Sinapi Biomedical, ATMOS MedizinTechnik GmbH & Co. KG, Medela AG, and others are the prominent players in the market.
North America held the highest market share in the thoracic drainage devices market.
Asia Pacific is expected to be the fastest growing market over the forecast period.